DE69405999D1 - Pharmazeutisch wirksame enantiomere - Google Patents

Pharmazeutisch wirksame enantiomere

Info

Publication number: DE69405999D1
Authority: DE; Germany
Prior art keywords: pharmaceutical effective; enantiomers; effective enantiomers; pharmaceutical; alk
Prior art date: 1993-07-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69405999T

Other languages

English (en)

Other versions

DE69405999T2 (de

Inventor

Leandro Baiocchi

Valerio Cioli

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Angelini Ricerche SpA

Original Assignee

Angelini Ricerche SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-01

Filing date

1994-06-21

Publication date

1997-11-06

1994-06-21 Application filed by Angelini Ricerche SpA filed Critical Angelini Ricerche SpA

1997-11-06 Publication of DE69405999D1 publication Critical patent/DE69405999D1/de

1998-04-16 Application granted granted Critical

1998-04-16 Publication of DE69405999T2 publication Critical patent/DE69405999T2/de

2014-06-22 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Epoxy Compounds (AREA)

DE69405999T 1993-07-01 1994-06-21 Pharmazeutisch wirksame enantiomere Expired - Fee Related DE69405999T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT93MI001418A IT1268414B1 (it)	1993-07-01	1993-07-01	Enantiomeri farmacologicamente attivi
PCT/EP1994/002061 WO1995001354A1 (en)	1993-07-01	1994-06-21	Pharmacologically active enantiomers

Publications (2)

Publication Number	Publication Date
DE69405999D1 true DE69405999D1 (de)	1997-11-06
DE69405999T2 DE69405999T2 (de)	1998-04-16

Family

ID=11366510

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69405999T Expired - Fee Related DE69405999T2 (de)	1993-07-01	1994-06-21	Pharmazeutisch wirksame enantiomere

Country Status (30)

Country	Link
US (3)	US5741907A (de)
EP (1)	EP0707587B1 (de)
JP (1)	JP3096065B2 (de)
KR (1)	KR100306018B1 (de)
CN (3)	CN1046281C (de)
AT (1)	ATE158796T1 (de)
AU (1)	AU689478B2 (de)
BG (1)	BG61815B1 (de)
BR (1)	BR9406996A (de)
CA (1)	CA2166470C (de)
CZ (1)	CZ289526B6 (de)
DE (1)	DE69405999T2 (de)
DK (1)	DK0707587T3 (de)
ES (1)	ES2111309T3 (de)
FI (1)	FI111943B (de)
GE (1)	GEP19991791B (de)
GR (1)	GR3025806T3 (de)
HK (2)	HK1018777A1 (de)
HU (1)	HU221631B1 (de)
IT (1)	IT1268414B1 (de)
LV (1)	LV11546B (de)
NO (1)	NO305957B1 (de)
NZ (1)	NZ268014A (de)
PL (1)	PL181831B1 (de)
RO (2)	RO116899B1 (de)
RU (1)	RU2128180C1 (de)
SK (1)	SK281060B6 (de)
UA (1)	UA53607C2 (de)
WO (1)	WO1995001354A1 (de)
ZA (1)	ZA944570B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1268414B1 (it) *	1993-07-01	1997-02-27	Angelini Francesco Ist Ricerca	Enantiomeri farmacologicamente attivi
JP2009018992A (ja) *	2007-07-10	2009-01-29	Sumitomo Chemical Co Ltd	光学活性ミルタザピンの製造方法
RU2706700C1 (ru)	2019-09-24	2019-11-20	Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ"	Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3365453A (en) *	1963-10-28	1968-01-23	Sterling Drug Inc	1-phenyl-4-lower-alkyl-2-piperazinones
IT1066857B (it) *	1965-12-15	1985-03-12	Acraf	Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US5303837A (en) *	1991-03-05	1994-04-19	Portola Packaging, Inc.	One-piece fitment and plug with tamper-evident band
GEP20001939B (en) *	1992-01-17	2000-02-05	Angelini Ricerca S P A Soc Consortile	Alkyl Derivatives of Trazodone with CNS Activity
US5543563A (en) *	1992-01-17	1996-08-06	Istituto Ricerca Francesco Angelini S.P.A.	Alkyl derivatives of trazodone with CNS activity
IT1268414B1 (it) *	1993-07-01	1997-02-27	Angelini Francesco Ist Ricerca	Enantiomeri farmacologicamente attivi
US5399765A (en) *	1994-05-23	1995-03-21	Sepracor, Inc.	Enantioselective preparation of optically pure albuterol

1993
- 1993-07-01 IT IT93MI001418A patent/IT1268414B1/it active IP Right Grant
1994
- 1994-06-21 WO PCT/EP1994/002061 patent/WO1995001354A1/en active IP Right Grant
- 1994-06-21 KR KR1019950705994A patent/KR100306018B1/ko not_active IP Right Cessation
- 1994-06-21 RU RU96104371A patent/RU2128180C1/ru not_active IP Right Cessation
- 1994-06-21 CZ CZ19953485A patent/CZ289526B6/cs not_active IP Right Cessation
- 1994-06-21 BR BR9406996A patent/BR9406996A/pt not_active Application Discontinuation
- 1994-06-21 NZ NZ268014A patent/NZ268014A/xx not_active IP Right Cessation
- 1994-06-21 HU HU9503876A patent/HU221631B1/hu not_active IP Right Cessation
- 1994-06-21 AU AU70729/94A patent/AU689478B2/en not_active Ceased
- 1994-06-21 AT AT94919660T patent/ATE158796T1/de not_active IP Right Cessation
- 1994-06-21 CN CN94193226A patent/CN1046281C/zh not_active Expired - Fee Related
- 1994-06-21 RO RO95-02315A patent/RO116899B1/ro unknown
- 1994-06-21 EP EP94919660A patent/EP0707587B1/de not_active Expired - Lifetime
- 1994-06-21 DK DK94919660.4T patent/DK0707587T3/da active
- 1994-06-21 RO ROA200100015A patent/RO121031B1/ro unknown
- 1994-06-21 JP JP07503250A patent/JP3096065B2/ja not_active Expired - Fee Related
- 1994-06-21 CA CA002166470A patent/CA2166470C/en not_active Expired - Fee Related
- 1994-06-21 DE DE69405999T patent/DE69405999T2/de not_active Expired - Fee Related
- 1994-06-21 UA UA96010331A patent/UA53607C2/uk unknown
- 1994-06-21 US US08/564,276 patent/US5741907A/en not_active Expired - Fee Related
- 1994-06-21 GE GEAP19943025A patent/GEP19991791B/en unknown
- 1994-06-21 ES ES94919660T patent/ES2111309T3/es not_active Expired - Lifetime
- 1994-06-21 PL PL94312419A patent/PL181831B1/pl not_active IP Right Cessation
- 1994-06-21 SK SK1664-95A patent/SK281060B6/sk not_active IP Right Cessation
- 1994-06-24 ZA ZA944570A patent/ZA944570B/xx unknown
1995
- 1995-12-29 FI FI956334A patent/FI111943B/fi active
- 1995-12-29 NO NO955345A patent/NO305957B1/no unknown
1996
- 1996-01-26 LV LVP-96-17A patent/LV11546B/en unknown
- 1996-02-01 BG BG100331A patent/BG61815B1/bg unknown
1997
- 1997-12-22 US US08/995,988 patent/US5817815A/en not_active Expired - Fee Related
- 1997-12-30 GR GR970403452T patent/GR3025806T3/el unknown
1998
- 1998-05-13 US US09/076,845 patent/US5973150A/en not_active Expired - Fee Related
- 1998-07-29 CN CNB981166601A patent/CN1136200C/zh not_active Expired - Fee Related
- 1998-07-29 CN CNB98116661XA patent/CN1136201C/zh not_active Expired - Fee Related
1999
- 1999-09-02 HK HK99103792A patent/HK1018777A1/xx not_active IP Right Cessation
- 1999-09-02 HK HK99103799A patent/HK1018781A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI956334A (fi)	1996-02-19
US5817815A (en)	1998-10-06
CN1136201C (zh)	2004-01-28
RO121031B1 (ro)	2006-11-30
NO955345D0 (no)	1995-12-29
ITMI931418A1 (it)	1995-01-01
AU689478B2 (en)	1998-04-02
CN1129939A (zh)	1996-08-28
HU9503876D0 (en)	1996-02-28
DK0707587T3 (da)	1998-05-11
HU221631B1 (hu)	2002-12-28
US5741907A (en)	1998-04-21
FI956334A0 (fi)	1995-12-29
US5973150A (en)	1999-10-26
JP3096065B2 (ja)	2000-10-10
LV11546A (lv)	1996-10-20
CA2166470A1 (en)	1995-01-12
AU7072994A (en)	1995-01-24
GR3025806T3 (en)	1998-03-31
CZ348595A3 (en)	1996-04-17
GEP19991791B (en)	1999-10-05
CN1046281C (zh)	1999-11-10
SK281060B6 (sk)	2000-11-07
ATE158796T1 (de)	1997-10-15
PL181831B1 (pl)	2001-09-28
RO116899B1 (ro)	2001-07-30
FI111943B (fi)	2003-10-15
RU2128180C1 (ru)	1999-03-27
HUT73230A (en)	1996-07-29
BG61815B1 (bg)	1998-06-30
EP0707587A1 (de)	1996-04-24
DE69405999T2 (de)	1998-04-16
EP0707587B1 (de)	1997-10-01
BR9406996A (pt)	1996-09-10
JPH08512036A (ja)	1996-12-17
NZ268014A (en)	1997-08-22
ZA944570B (en)	1995-04-11
LV11546B (en)	1997-02-20
SK166495A3 (en)	1996-09-04
NO305957B1 (no)	1999-08-23
BG100331A (bg)	1996-09-30
PL312419A1 (en)	1996-04-15
CN1136200C (zh)	2004-01-28
CN1215053A (zh)	1999-04-28
CA2166470C (en)	2001-12-18
NO955345L (no)	1996-02-29
KR100306018B1 (ko)	2001-11-30
ES2111309T3 (es)	1998-03-01
CZ289526B6 (cs)	2002-02-13
UA53607C2 (uk)	2003-02-17
HK1018777A1 (en)	2000-01-07
HK1018781A1 (en)	2000-01-07
WO1995001354A1 (en)	1995-01-12
CN1215052A (zh)	1999-04-28
ITMI931418A0 (it)	1993-07-01
IT1268414B1 (it)	1997-02-27

Publication	Publication Date	Title
LU88670I2 (fr)	1996-04-29	Fluvastatine eventuellement sous forme de sel par exemple sel de sodium
KR880000400A (ko)	1988-03-25	융합된 사이클릭 아제핀-2-온 유도체 및 그의 제조방법
ES8802420A1 (es)	1988-06-01	Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
EP0154234A3 (de)	1987-05-27	Substituierte Tyrosyl-Alanin-Dipeptid-Amide
ES2001341A6 (es)	1988-05-16	Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
DE69405999D1 (de)	1997-11-06	Pharmazeutisch wirksame enantiomere
DK0427518T3 (da)	1995-07-24	NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
AU586477B2 (en)	1989-07-13	Hexenoic acids
ATE86117T1 (de)	1993-03-15	Zusammensetzung gegen leberkrankheiten.
ATE18993T1 (de)	1986-04-15	Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
ATE151987T1 (de)	1997-05-15	Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
CA2078141A1 (en)	1991-09-15	Acyl phosphate esters and modification of proteins therewith
AU7384381A (en)	1982-02-18	Substituted oxadiazoles
DE3782229D1 (de)	1992-11-19	Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
AU2013888A (en)	1989-02-02	Uricosuric composition

Legal Events

Date	Code	Title	Description
1998-10-29	8364	No opposition during term of opposition
2010-04-22	8339	Ceased/non-payment of the annual fee